Skip to main content
. 2020 Jun 15;48(13):7027–7040. doi: 10.1093/nar/gkaa504

Figure 3.

Figure 3.

Level of methylated miR-21-5p in sera from NSCLC patients and healthy donors. (A) Elevation of methylated miR-21-5p level in serum samples from NSCLC patients (n = 21) than that from healthy donors (n = 11). (B) Decrease of methylated miR-21-5p level in serum samples from NSCLC patients (n = 20) before and after tumor removal by surgery. **P < 0.01, ***P < 0.001.